Study guide
19.1 Benign and Malignant Oral Mucosal Lesions (Leukoplakia, Lichen Planus, OSCC)
Saudi Dental Licensure Examination SDLE / SPLE - Dentist
Track your progress as you read
Finished sections get a check mark.
1 Introduction
About the SDLE: Format, Scoring, Eligibility, Attempts & Blueprint
2 Chapter 1: Operative Dentistry & Caries Management
1.1 Caries Etiology, Histopathology, and Risk Assessment (CAMBRA / ICDAS) 1.2 Cavity Preparation Principles and Tooth Isolation (Rubber Dam Mechanics) 1.3 Direct Composite Resin Restorations, Adhesion & Curing Dynamics 1.4 Indirect Inlays and Onlays, Minimally Invasive Restorations, Finishing and Repair
3 Chapter 2: Direct Restorations & Dental Biomaterials
2.1 Dental Amalgam Restorations, Matrix Systems & Proximal Contact Mechanics 2.2 Glass Ionomer Cements, Resin-Modified Glass Ionomers & Bioactive Materials 2.3 Dental Bonding Agents (Etch-and-Rinse vs. Self-Etch vs. Universal Systems) 2.4 Direct Pulp Capping, Indirect Pulp Capping & Pulpal Protection Liners
4 Chapter 3: Fixed Prosthodontics — Treatment Planning & Tooth Preparation
3.1 Fixed Partial Denture Treatment Planning: Abutments, Pontics and Endodontically Treated Teeth 3.2 Biological, Mechanical, and Esthetic Principles of Crown Preparations 3.3 Finish Lines and Margin Geometries (Chamfer, Shoulder, Feather-Edge) 3.4 Temporary/Provisional Restorations & Tissue Management (Gingival Retraction) 3.5 Impression Techniques, Digital Scanning & Working Casts
5 Chapter 4: Fixed Prosthodontics — Materials, Luting, Esthetics & Delivery
4.1 Dental Ceramics (Feldspathic, Lithium Disilicate, Zirconia) & Metal-Ceramics 4.2 Dental Cements and Luting Protocols (Zinc Phosphate, GI, RMGI, Resin) 4.3 Shade Selection, Color Science, and Esthetic Veneers 4.4 Fixed Prosthesis Try-In, Delivery, Complications and Repair
6 Chapter 5: Removable Partial Dentures
5.1 Removable Partial Dentures: Kennedy Classification, Rests, and Major Connectors 5.2 RPD Direct Retainers, Indirect Retainers & Surveying Principles 5.3 RPD Design Sequence, Mouth Preparation, Impressions, Try-In, Delivery and Maintenance
7 Chapter 6: Complete Dentures
6.1 Complete Denture Anatomy, Border Molding & Secondary Impressions 6.2 Maxillomandibular Relationships, Vertical Dimension & Occlusion Schemes 6.3 Complete Denture Diagnosis, Try-In, Insertion, Post-Insertion Problems and Relining
8 Chapter 7: Dental Anatomy, Occlusion & Articulators
7.1 Dental Anatomy: Tooth Notation, Permanent Tooth Morphology and Identification 7.2 Principles of Occlusion (Centric Relation, MIC, Canine Guidance, Group Function) 7.3 Articulators, Facebow Transfers & Occlusal Splints
9 Chapter 8: Basic Implantology
8.1 Basic Implantology: Patient Assessment, Treatment Planning and Implant Positioning 8.2 Implant Prosthodontics: Biomechanics, Abutment Types & Loading Protocols
10 Chapter 9: Ethics, Professionalism, Infection Control & Patient Safety
9.1 Ethics, Professionalism and Saudi Health Practice Law 9.2 Infection Control and Patient Safety in the Dental Clinic
11 Chapter 10: Periodontal Anatomy, Classification, Etiology & Pathology
10.1 Anatomy of the Periodontium and Biologic Width 10.2 2017 AAP/EFP World Workshop Classification (Staging and Grading) 10.3 Periodontal Microbiology, Host Response & Systemic Risk Factors 10.4 Applied Periodontal Pathology: Lesion Stages, Necrotizing Disease, Abscesses and Gingival Enlargement
12 Chapter 11: Periodontal Examination & Non-Surgical Therapy
11.1 Clinical Periodontal Assessment, Probing, Mobility & Furcation Involvement 11.2 Scaling and Root Planing, Ultrasonic Instrumentation & Full-Mouth Disinfection 11.3 Antimicrobial Therapy, Host Modulation & Periodontal Maintenance
13 Chapter 12: Surgical Periodontics, Peri-Implant Disease & Multidisciplinary Care
12.1 Periodontal Flap Surgery & Resective Osseous Surgery 12.2 Regenerative Periodontal Therapy (GTR, Bone Grafts, Enamel Matrix Derivatives) 12.3 Mucogingival Deformities, Soft Tissue Grafting & Peri-Implant Diseases (Mucositis vs. Peri-Implantitis) 12.4 Iatrogenic Factors, Occlusal Trauma and Multidisciplinary Periodontal Care
14 Chapter 13: Pulpal & Periapical Pathology, Diagnosis & Endodontic Treatment Planning
13.1 Pulpal Biology, Pathogenesis, and Diagnostic Terminology (AAE Classification) 13.2 Diagnostic Testing Modalities (Thermal, Electric, Percussion, Palpation, CBCT) 13.3 Endodontic Treatment Planning, Case Difficulty, Retreatment, Apical Surgery and Outcomes
15 Chapter 14: Endodontic Treatment: Anatomy, Access, Shaping & Irrigation
14.1 Internal Tooth Anatomy and Endodontic Access Cavity Preparation 14.2 Root Canal Instrumentation: Hand, Rotary, and Reciprocating Nickel-Titanium 14.3 Endodontic Irrigants (NaOCl, EDTA, CHX), Intracanal Medicaments & Smear Layer
16 Chapter 15: Obturation, Mishaps, Emergencies, Trauma & Endo-Perio Lesions
15.1 Root Canal Obturation Techniques (Cold Lateral, Warm Vertical, Bioceramic Sealers) 15.2 Management of Procedural Accidents (Ledges, Perforations, Separated Instruments) 15.3 Endodontic Emergencies, Flare-ups & Traumatic Dental Injuries (Luxations, Avulsion) 15.4 Endodontic-Periodontal Lesions, Cracked Teeth and Vertical Root Fractures
17 Chapter 16: Local Anesthesia, Surgical Principles, Biopsy & Exodontia
16.1 Local Anesthetics, Vasoconstrictors, Dosages & Nerve Block Techniques 16.2 Principles of Oral Surgery, Suturing, Wound Healing and Biopsy Techniques 16.3 Exodontia Principles, Surgical Extraction & Management of Impacted Third Molars 16.4 Post-Extraction Complications (Alveolar Osteitis, Hemorrhage, Oroantral Fistula)
18 Chapter 17: Odontogenic Infections, Maxillofacial Trauma & Dentofacial Deformities
17.1 Odontogenic Infections, Fascial Space Spread & Ludwig's Angina 17.2 Maxillofacial Trauma and Dentofacial Deformities
19 Chapter 18: Medical Emergencies & Medically Compromised Patients
18.1 Dental Office Medical Emergencies (Syncope, Anaphylaxis, Angina, Hypoglycemia) 18.2 Management of Medically Compromised Dental Patients (Cardiovascular, Anticoagulated, Diabetic) 18.3 Dental Management of Hematologic and Oncology Patients 18.4 Endocrine, Hepatic, Renal, Pulmonary, Neurological and Psychiatric Conditions in Dental Practice
20 Chapter 19: Oral Mucosal, Infectious, Immunologic & Salivary Gland Pathology
19.1 Benign and Malignant Oral Mucosal Lesions (Leukoplakia, Lichen Planus, OSCC) 19.2 Microbiological Infections of the Oral Mucosa: Fungal, Viral and Bacterial 19.3 Immunologic and Allergic Conditions, Reactive Lesions and Physical or Chemical Injuries 19.4 Salivary Gland Diseases: Obstruction, Infection, Sjögren Syndrome and Tumors
21 Chapter 20: Jaw Pathology & Abnormalities of Teeth
20.1 Odontogenic Cysts and Tumors (Radicular Cyst, Dentigerous Cyst, OKCs, Ameloblastoma) 20.2 Bone Pathology of the Jaws: Fibro-Osseous Lesions, Giant Cell Lesions, Osteomyelitis and Malignancy 20.3 Abnormalities of Teeth and Developmental Defects of the Oral Region
22 Chapter 21: Orofacial Pain, TMD & Neuromuscular Disorders
21.1 Differential Diagnosis of Odontogenic vs. Non-Odontogenic Orofacial Pain 21.2 Temporomandibular Disorders and Neuromuscular Conditions
23 Chapter 22: Orthodontic Growth, Diagnosis & Treatment Planning
22.1 Craniofacial Growth, Development & Angle's Malocclusion Classification 22.2 Cephalometric Landmarks, Analysis & Biology of Orthodontic Tooth Movement 22.3 Etiology of Malocclusion, Orthodontic Diagnosis and Treatment Planning
24 Chapter 23: Orthodontic Treatment: Interceptive, Skeletal, Canines & Fixed Appliances
23.1 Interceptive Orthodontics, Serial Extraction & Space Maintainers (Band and Loop, Nance, Lingual Arch) 23.2 Management of Class I, Class II, Class III and Skeletal Problems 23.3 Ectopic and Impacted Maxillary Canines 23.4 Fixed Appliances, Anchorage, Adult Orthodontics and Retention
25 Chapter 24: Pediatric Dentistry: Development, Behavior, Caries & Restorative Care
24.1 Dental Development, Eruption Chronology and Examination of the Child 24.2 Pediatric Behavior Guidance, Nitrous Oxide & Early Childhood Caries (ECC) 24.3 Pediatric Caries Prevention and Restorative Dentistry: Sealants, ART, Crowns and Material Choice
26 Chapter 25: Pediatric Pulp Therapy, Pain Management, Oral Surgery, Trauma & Child Protection
25.1 Pediatric Pulp Therapy (Pulpotomy vs. Pulpectomy) and Stainless Steel Crowns 25.2 Pediatric Local Anesthesia, Pain Management and Pediatric Oral Surgery 25.3 Traumatic Injuries to the Primary Dentition and Recognition of Child Abuse and Neglect
19.1 Benign and Malignant Oral Mucosal Lesions (Leukoplakia, Lichen Planus, OSCC)
Key Takeaways Explain This Topic AI
Oral erythroplakia exhibits the highest rate of malignant transformation among all potentially malignant oral disorders (PMODs), with over 90% demonstrating severe epithelial dysplasia, carcinoma in situ, or invasive squamous cell carcinoma upon mandatory incisional scalpel biopsy.
Oral leukoplakia is a clinical diagnosis of exclusion; non-homogenous variants (speckled/erythroleukoplakic, nodular, verrucous) carry a 4- to 5-fold higher risk of malignant progression than homogenous leukoplakia, with the ventrolateral tongue, floor of the mouth, and soft palate representing the highest-risk anatomical sites.
In Saudi Arabia, regional forms of smokeless tobacco, specifically shammah (powdered tobacco with lime and ash) and toombak (a Sudanese fermented snuff), are potent cultural etiologic agents strongly linked to aggressive oral squamous cell carcinoma localized to the mandibular labial and buccal vestibules.
Oral lichen planus is a chronic T-cell mediated autoimmune dermatosis characterized histopathologically by hyperkeratosis with saw-tooth rete ridges, basal layer vacuolar degeneration with apoptotic Civatte bodies, and a dense band-like subepithelial T-lymphocyte infiltrate hugging the basement membrane; the erosive subtype carries an estimated 1-2% risk of malignant transformation.
Pemphigus vulgaris produces intraepithelial suprabasilar acantholysis and flaccid bullae with a positive Nikolsky sign due to anti-desmoglein 3 autoantibodies (fishnet pattern on DIF), whereas mucous membrane pemphigoid causes a subepithelial split with tense bullae and blinding cicatricial ocular complications due to anti-basement membrane autoantibodies (linear band on DIF).
Last updated: October 2026
Oral mucosal lesions encompass a wide spectrum of developmental, reactive, autoimmune, infectious, and neoplastic pathologies. The primary responsibility of the dental surgeon is early detection, accurate risk stratification, definitive diagnostic biopsy, and management of potentially malignant oral disorders (PMODs) and frank oral malignancies.
Potentially Malignant Oral Disorders (PMOD)
The World Health Organization (WHO) defines Potentially Malignant Oral Disorders as clinical presentations that carry a significantly increased statistical risk of developing oral squamous cell carcinoma, either in an existing lesion or elsewhere in clinically normal-appearing oral mucosa.
1. Oral Leukoplakia
Definition: A predominantly white plaque or patch of questionable risk having excluded (other) known diseases or disorders that carry no increased risk for cancer. Clinically, it cannot be scraped off (differentiating it from pseudomembranous candidiasis) and cannot be categorized clinically or histologically as any other specific white lesion (e.g., leukoedema, morsicatio buccarum, white sponge nevus, or frictional keratosis).
Clinical Subtypes:
Homogenous Leukoplakia: A uniform, thin, flat, smooth, cracked, or wrinkled white plaque with clearly demarcated borders. Histopathologically, it typically exhibits hyperkeratosis with little to no epithelial dysplasia. Malignant transformation rate is relatively low ( 1% to 5% ).
Non-Homogenous Leukoplakia: Irregular surface topography, categorized into:
Speckled Leukoplakia (Erythroleukoplakia): Mixed red and white patches.
Nodular Leukoplakia: Small, round, exophytic papillary nodules.
Verrucous Leukoplakia: Heavily keratinized, corrugated, exophytic projections (including Proliferative Verrucous Leukoplakia [PVL], a highly aggressive, multifocal, treatment-resistant PMOD with >60% malignant conversion).
Clinical Significance: Non-homogenous leukoplakias carry a 4- to 5-fold higher malignant transformation rate (20% to 40%) compared to homogenous variants.
High-Risk Anatomical Sites: The biological behavior of leukoplakia depends strongly on anatomical location. High-risk oral subsites with the greatest propensity for dysplasia and malignant transformation are:
- Ventrolateral border of the tongue
- Floor of the mouth
- Soft palate and retromolar trigone complex HISTOPATHOLOGICAL GRADING OF EPITHELIAL DYSPLASIA
- MILD DYSPLASIA MODERATE DYSPLASIA SEVERE DYSPLASIA
- (Lower 1/3 Epithelium) (Lower 2/3 Epithelium) (> 2/3 of Epithelium)
- ────────────────────── ────────────────────── ─────────────────────
- Keratin Layer Keratin Layer Keratin Layer
- ┌──────────────┐ ┌──────────────┐ ┌──────────────┐
- │ Normal Upper │ │ Normal Upper │ │ Dysplastic │
- │ 2/3 Cells │ │ 1/3 Cells │ │ Cells │
- ├──────────────┤ ├──────────────┤ │ Throughout │
- │ Dysplastic │ │ Dysplastic │ │ Entire │
- │ Basal / Para │ │ Cells Extend │ │ Thickness │
- │ basal Layer │ │ into Spinous │ │ │
- └──────────────┘ └──────────────┘ └──────────────┘
- Basement Membrane Basement Membrane Basement Membrane
- (Intact) (Intact) (Intact: No Invasion)
- Epithelial Dysplasia: Architectural and Cytological Criteria
Epithelial dysplasia represents disordered cellular proliferation and maturation without invasion through the basement membrane:
Architectural Abnormalities: Loss of basal cell polarity, irregular epithelial stratification, bulbous or teardrop-shaped rete pegs, premature keratinization of single cells within the spinous layer (dyskeratosis), abnormal intraepithelial keratin pearl formation, and abnormal superficial mitotic figures.
Cytological Abnormalities: Cellular and nuclear pleomorphism, hyperchromatic nuclei, increased nuclear-to-cytoplasmic (N:C) ratio, enlarged and multiple nucleoli, and atypical (multipolar) mitotic figures.
Grades of Dysplasia:
Mild: Atypia restricted to the lower third (basal and parabasal layers).
Moderate: Atypia extending into the middle third of the spinous layer.
Severe: Atypia occupying more than two-thirds of the epithelial thickness.
Carcinoma in Situ (CIS): Full-thickness cytological atypia spanning the entire epithelial height from basal layer to surface, with an intact basement membrane (zero stromal invasion).
2. Oral Erythroplakia
Definition: A fiery red, velvety patch or plaque that cannot be characterized clinically or pathologically as any other specific inflammatory, fungal, or vascular condition.
Warning
Oral erythroplakia carries the highest malignant transformation rate of all potentially malignant oral disorders (PMODs), with over 90% demonstrating severe epithelial dysplasia, carcinoma in situ, or invasive squamous cell carcinoma upon initial histopathology. Never monitor an unexplained, persistent red or speckled velvety lesion or delay care with empiric antifungal trials; prompt incisional scalpel biopsy is mandatory.
Clinical Significance: Erythroplakia is the most dangerous of all oral PMODs . Upon mandatory incisional scalpel biopsy, greater than 90% of all oral erythroplakias reveal severe epithelial dysplasia, carcinoma in situ, or invasive squamous cell carcinoma at the time of initial presentation.
Management Protocol: Immediate, mandatory incisional scalpel biopsy. Watchful waiting or topical antifungal trials are strictly contraindicated for unexplained persistent red velvety lesions.
Oral Squamous Cell Carcinoma (OSCC)
Oral Squamous Cell Carcinoma accounts for greater than 90% of all oral malignancies. It is a malignant epithelial neoplasm exhibiting varying degrees of squamous differentiation, characterized by local invasion into surrounding connective tissues, bone, and early lymphatic dissemination.
Etiological Factors: Regional Cultural Practices in Saudi Arabia
Combustible Tobacco and Alcohol: Chronic cigarette and shisha (waterpipe) smoking releases polycyclic aromatic hydrocarbons and tobacco-specific nitrosamines (NNK, NNN). Alcohol functions as a potent synergistic co-carcinogen, acting as a chemical solvent that enhances mucosal permeability to tobacco carcinogens and impairing hepatic detoxification.
Smokeless Tobacco in Saudi Arabia (Shammah and Toombak):
Shammah: A traditional oral smokeless tobacco mixture widely consumed in the southwestern provinces of Saudi Arabia (Jazan, Najran, and Asir). It consists of powdered tobacco leaves, slaked lime (calcium hydroxide), ash, black pepper, oils, and flavorings. The alkaline lime elevates intraoral pH, accelerating unionized nicotine absorption through the oral mucosa.
Toombak: Fermented, sun-dried tobacco paste combined with sodium bicarbonate; it originates in Sudan and is used by Sudanese communities, including in the Gulf. It contains exceptionally high concentrations of carcinogenic tobacco-specific N N N -nitrosamines (thousands of times higher than manufactured cigarettes).
Clinical Pattern: Habitual placement of shammah or toombak in the lower labial or buccal vestibule results in localized "snuff dipper's pouch" keratosis , marked epithelial atrophy, severe mucosal dysplasia, and aggressive vestibular and alveolar squamous cell carcinoma, often presenting in younger populations.
Human Papillomavirus (HPV): High-risk HPV genotypes ( HPV-16 and HPV-18 ) encode oncoproteins E6 (which induces ubiquitination and degradation of p53 tumor suppressor) and E7 (which inactivates retinoblastoma protein pRb, resulting in reciprocal overexpression of p16INK4a ). HPV is the primary driver of oropharyngeal squamous cell carcinoma (lingual and palatine tonsils, base of tongue), classically affecting younger, non-smoking, non-drinking individuals, with a significantly better prognosis than tobacco-related OSCC.
Clinical Presentation of OSCC
An indurated, painless or painful ulcer that fails to heal within 2 to 3 weeks .
Classically exhibits raised, rolled, everted, and indurated margins with an irregular, necrotic, granular floor.
Exophytic fungating masses or endophytic indurated infiltrative lesions.
Pain radiating to the ear (referred otalgia via cranial nerve IX or V3).
Unexplained mobility of teeth, paresthesia of the lip/chin (mental nerve involvement), or non-healing extraction sockets.
Cervical lymphadenopathy: Hard, fixed, non-tender, matted lymph nodes in levels I (submandibular/submental) and II (upper jugular).
TNM Clinical Staging (AJCC 8th Edition)
The AJCC 8th edition staging incorporates Depth of Invasion (DOI) into the T-category and Extranodal Extension (ENE) into the N-category:
T Category (Primary Tumor):
T1: Tumor ≤ 2 cm \le 2\text{ cm} ≤ 2 cm with DOI ≤ 5 mm \text{DOI} \le 5\text{ mm} DOI ≤ 5 mm .
T2: Tumor ≤ 2 cm \le 2\text{ cm} ≤ 2 cm with DOI > 5 mm \text{DOI} > 5\text{ mm} DOI > 5 mm and ≤ 10 mm \le 10\text{ mm} ≤ 10 mm , OR tumor > 2 cm > 2\text{ cm} > 2 cm but ≤ 4 cm \le 4\text{ cm} ≤ 4 cm with DOI ≤ 10 mm \text{DOI} \le 10\text{ mm} DOI ≤ 10 mm .
T3: Tumor > 4 cm > 4\text{ cm} > 4 cm OR any tumor with DOI > 10 mm \text{DOI} > 10\text{ mm} DOI > 10 mm .
T4a: Moderately advanced local disease (invading cortical bone of mandible/maxilla, maxillary sinus, or facial skin).
N Category (Regional Lymph Nodes): N0 = no regional metastasis; N1 = single ipsilateral node ≤ 3 cm \le 3\text{ cm} ≤ 3 cm without ENE; N2 = single ipsilateral node 3–6 cm, or multiple ipsilateral nodes ≤ 6 cm \le 6\text{ cm} ≤ 6 cm , or bilateral/contralateral nodes ≤ 6 cm \le 6\text{ cm} ≤ 6 cm without ENE; N3 = node > 6 cm > 6\text{ cm} > 6 cm or any node with clinical extranodal extension (ENE+) .
M Category: M0 = no distant metastasis; M1 = distant metastasis (lungs, bone, liver).
Oral Lichen Planus (OLP)
Oral Lichen Planus is a chronic, mucocutaneous inflammatory disease mediated by an antigen-specific, T-cell mediated autoimmune response targeting basal keratinocytes. IMMUNOPATHOGENESIS OF ORAL LICHEN PLANUS
- [Altered Basal Keratinocyte Antigen] ──► [CD4+ Helper T-Cells Release IFN-γ]
- │
- ▼
- [Apoptosis of Basal Keratinocytes] ◄──── [Recruitment of Cytotoxic CD8+ T-Cells]
- (Civatte / Cytoid Bodies Form) (Perforin / Granzyme B Release)
- │
- ▼
- [Dense, Band-Like Subepithelial
- T-Cell Infiltrate at BMZ]
- Clinical Variants
Reticular Lichen Planus: The most common and classic form. Clinically asymptomatic, presenting with bilateral, symmetrical, interlacing slender white keratotic lines and lace-like networks known as Wickham's striae . Most frequently located on the posterior buccal mucosa, lateral tongue margins, and attached gingiva. Does not require active immunosuppressive intervention.
Erosive / Atrophic Lichen Planus: Clinically symptomatic and painful. Characterized by extensive areas of mucosal erythema, shallow irregular ulcers, and peripheral radiating white Wickham's striae. When confined to the attached and marginal gingiva, it presents as desquamative gingivitis (fiery red, glazed, peeling gingiva).
Malignant Transformation: While previously disputed, long-term prospective studies demonstrate that erosive/atrophic OLP carries an estimated 1% to 2% lifetime risk of malignant transformation to oral squamous cell carcinoma, requiring indefinite biannual clinical surveillance.
Histopathological Triad of Lichen Planus
Hyperkeratosis: Prominent orthokeratosis or parakeratosis with characteristic "saw-tooth" pointed rete ridges .
Basal Layer Liquefaction Degeneration: Hydropic degeneration and necrosis of basal keratinocytes, resulting in the formation of round, eosinophilic, apoptotic cellular bodies termed Civatte bodies (colloid or cytoid bodies) .
Band-Like Lymphocytic Infiltrate: A dense, continuous, sharply demarcated band-like subepithelial infiltrate of T-lymphocytes (CD4+ and CD8+) confined strictly to the upper lamina propria and tightly hugging the dermo-epidermal junction.
Pharmacological Management
First-Line Therapy (Symptomatic Erosive OLP): High-potency topical corticosteroids. Clobetasol propionate 0.05% gel/ointment or Fluocinonide 0.05% gel mixed 1:1 with an adhesive paste (Orabase) applied to dried lesions 3 to 4 times daily after meals.
Secondary Prophylaxis: Prolonged topical corticosteroid therapy frequently precipitates secondary oral candidiasis. Prescribe concurrent topical antifungals (e.g., miconazole oral gel or nystatin oral suspension).
Autoimmune Bullous Diseases: Pemphigus Vulgaris vs. Mucous Membrane Pemphigoid
Autoimmune vesiculobullous diseases present with intraoral blistering, erosions, and desquamative gingivitis. Differentiating between Pemphigus Vulgaris and Mucous Membrane Pemphigoid is a critical clinical mandate because Pemphigus Vulgaris carries high mortality if untreated. HISTOLOGICAL CLEAVAGE PLANES IN BLISTER FORMATION
- PEMPHIGUS VULGARIS MUCOUS MEMBRANE PEMPHIGOID
- (Suprabasilar Split / Acantholysis) (Subepithelial Split at BMZ)
- ─────────────────────────────────── ────────────────────────────
- Keratin / Spinous Layer Intact, Full-Thickness
- ┌────────────────────────┐ Epithelium Forms Blister Roof
- │ Acantholytic Cells │ ┌────────────────────────┐
- │ (Tzanck Cells) │ │ │
- ├────────────────────────┤ ├────────────────────────┤
- │ [SUPRABASILAR SPLIT] │ ◄─── Blister Fluid │ [SUBEPITHELIAL SPLIT] │ ◄── Blister
- ├────────────────────────┤ ├────────────────────────┤
- │ "Row of Tombstones" │ (Basal Cells Stay) │ Intact Basement Membr. │
- ├────────────────────────┤ ├────────────────────────┤
- │ Connective Tissue │ │ Connective Tissue │
- └────────────────────────┘ └────────────────────────┘
- DIF: Fishnet IgG (Desmoglein 3) DIF: Linear IgG/C3 at BMZ
- Comparison: Pemphigus Vulgaris vs. Mucous Membrane Pemphigoid
Diagnostic Parameter Pemphigus Vulgaris (PV) Mucous Membrane Pemphigoid (MMP)
Autoantigen Target Desmoglein 3 (Dsg3) (and Dsg1) in intercellular desmosomes BP180 (type XVII collagen) , BP230, laminin 332 in hemidesmosomes / BMZ
Histological Cleavage Intraepithelial, suprabasilar split (acantholysis) Subepithelial split (clean separation of full-thickness epithelium)
Tzanck Cells Present (rounded, detached acantholytic spinous cells) Absent
Basal Cell Layer Attached to basement membrane ( "row of tombstones" ) Part of the elevated, intact blister roof
Clinical Blister Nature Flaccid, fragile bullae ; rupture immediately leaving ragged, painful erosions Tense, tough bullae ; may persist intact for 24–48 hours before rupturing
Nikolsky Sign Strongly positive (shearing normal mucosa induces blister) Negative or weakly positive
Direct Immunofluorescence Intracellular "fishnet" or "chicken-wire" IgG and C3 pattern between spinous cells Continuous, smooth, linear band of IgG and C3 along basement membrane zone
Systemic Hazards Potentially fatal without systemic therapy (fluid loss, sepsis) Ocular cicatrization / symblepharon leading to entropion, trichiasis, and blindness
Definitive Treatment High-dose systemic corticosteroids (prednisone) + Rituximab / Azathioprine Topical high-potency corticosteroids (Clobetasol) + urgent Ophthalmology consult
Ulcerative Lesions: Recurrent Aphthous Stomatitis (RAS) vs. Intraoral Herpes Simplex (HSV-1)
Diagnostic Parameter Recurrent Aphthous Stomatitis (RAS) Recurrent Intraoral Herpes Simplex Virus (HSV-1)
Etiology T-cell mediated immune dysregulation; non-infectious, non-viral Reactivation of latent HSV-1 residing in the trigeminal ganglion
Tissue Predilection Exclusively on NON-KERATINIZED, movable mucosa (buccal, labial, ventral tongue, floor of mouth) Exclusively on KERATINIZED mucosa firmly bound to periosteum (hard palate, attached gingiva)
Primary Lesion Never preceded by vesicles ; starts immediately as an ulcer Preceded by crops of pinhead-sized microvesicles that rapidly rupture
Ulcer Morphology Round/ovoid, shallow crater, yellow-gray fibrin base with a sharp, well-defined erythematous inflammatory halo Multiple tiny, punctate, coalescing erosions with ragged margins; cluster formation
Systemic Symptoms Absent in simple minor aphthae; present in complex aphthosis (Behçet's syndrome) Malaise, low-grade fever, regional lymphadenopathy during primary infection or severe flare
Microscopy / Cytology Non-specific ulceration with fibrinous exudate and mixed inflammatory cells Multinucleated epithelial giant cells , ballooning degeneration, and Cowdry type A intranuclear inclusions on Tzanck smear
Management Topical corticosteroids (triamcinolone in Orabase, clobetasol gel) Topical or oral antiviral therapy (Valacyclovir 1.0 g PO bid, Acyclovir 400 mg tid)